Red blood cell exchange techniques and methods

Dedeken, 2018, Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload, Transfusion, 58, 1356, 10.1111/trf.14575 Duclos, 2013, Long-term red blood cell exchange in children with sickle cell disease: manual or automatic?, Transfus Apher Sci, 48, 219, 10.1016/j.transci.2012.09.002 Kuo, 2015, A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients, Br J Haematol, 170, 425, 10.1111/bjh.13294 Schwartz, 2016, Guidelines on the use of therapeutic apheresis in clinical practice-evidence-Based approach for the writing committee of the american society for apheresis: the seventh special issue, J Clin Aph, 31, 149 Perseghin, 2013, Erythrocyte-exchange with the OPTIATM cell separator in patients with sickle-cell disease, J Clin Aph, 28, 411, 10.1002/jca.21293 Driss, 2007, Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange, Transfus Clin Biol, 14, 366 Wehrli, 2011, Therapeutic apheresis instrumentation, J Clin Aph, 26, 286, 10.1002/jca.20301 Kim, 2016, Comparison of Spectra Optia and COBE Spectra apheresis systems’ performances for red blood cell exchange procedures, Transfus Apher Sci, 55, 368, 10.1016/j.transci.2016.10.004 Quirolo, 2015, The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease, Transfusion, 55, 775, 10.1111/trf.12891 Ottrock, 2018, Vascular access for red blood cell exchange, Transfusion, 58, 569, 10.1111/trf.14495 Ullrich, 2008, Erythrocytapheresis: do not forget a useful therapy, Transfus Med Hemother, 35, 24, 10.1159/000112044 Faes, 2018, Hypercoagulable state in sickle cell disease, Clin Hemorheol Microcirc, 68, 301, 10.3233/CH-189013 Putensen, 2016, Is peripheral access for apheresis procedures underutilized in clinical practice? A single centre experience, J Clin Aph, 32, 501, 10.1002/jca.21440 Shönermarck, 2003, Vascular access for apheresis in intensive care patients, Ther Apher Dial, 7, 215, 10.1046/j.1526-0968.2003.00039.x Billard, 2013, Short-term femoral catheter insertion: a promising alternative to consistently allow long-term erythrocytapheresis therapy in children with sickle cell anemia, J Pediatr, 162, 423, 10.1016/j.jpeds.2012.09.009 Wagner, 2004, Infectious complications of implantable venous access in patients with sickle cell disease, J Vasc Interv Radiol, 15, 375, 10.1097/01.RVI.0000121410.46920.6E Delville, 2017, Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: complications and outcome, Am J Hematol, 92, 136, 10.1002/ajh.24600 Sarode, 2016, Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease, J Clin Apher, 32, 342, 10.1002/jca.21511 Davis, 2017, Guidelines on red cell transfusion in sickle cell disease Part II:indications for transfusion, Br J Hematol, 176, 192, 10.1111/bjh.14383 Schmalzer, 1987, Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion, Transfusion, 27, 228, 10.1046/j.1537-2995.1987.27387235626.x Yawn, 2014, Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members, JAMA, 312, 1033, 10.1001/jama.2014.10517 Kozanoglu, 2018, Use of red blood cell exchange for treating acute complications of sickle cell disease, Transfus Apher Sci, 57, 23, 10.1016/j.transci.2018.02.011 Yousafzai, 2010, Open heart surgery in patients with sickle cell hemoglobinopathy, Circulation, 121, 14, 10.1161/CIRCULATIONAHA.109.882464 Adams, 1998, Prevention of first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography, N Eng J Med, 339, 5, 10.1056/NEJM199807023390102 Adams, 2005, Optimizing primary stroke prevention in sickle cell anemia (STOP 2) trial investigators. Discontinuiting prophylactic transfusions used to prevent stroke in sickle cell disease, N Eng J Med, 353, 2769, 10.1056/NEJMoa050460 Scothorn, 2002, Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke, J Pediatr, 140, 348, 10.1067/mpd.2002.122498 Biller, 2018, Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB, Transfusion, 58, 1965, 10.1111/trf.14806 Sarode, 2011, Advantages of isovolemic hemodilution-red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patients, J Clin Aph, 26, 200, 10.1002/jca.20294 Poullin, 2015, Comparative evaluation of the depletion-red cell exchange program with the Spectra Optia and the isovolemic hemodilution-red cell exchange method with the Cobe Spectra in sickle cell disease patients, J Clin Aph, 31, 429, 10.1002/jca.21422 Matevosyan, 2012, Isovolemic hemodilution-red cell exchange for prevention of cerebrovascular accident in sickle cell anemia: the standard operating procedure, J Clin Aph, 27, 88, 10.1002/jca.21203 Govoni, 2015, Erythroexchange in sickle cell disease. A three-step procedure to remove more haemoglobin S, Blood Transfus, 13, 340 Perseghin, 2013, Erythrocyte-exchange in sickle-cell disease patients. A comparison between Caridian COBE Spectra and Optia cell separators, Transfus Apher Sci, 48, 177, 10.1016/j.transci.2013.02.025